Global Helminthic Infestations Therapeutics Market Research Report 2023

The global Helminthic Infestations Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Helminthic Infestations Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Helminthic Infestations Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Helminthic Infestations Therapeutics in Enterobius vermicularis is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Helminthic Infestations Therapeutics include Neural Analytics, Inc., M3 Biotechnology, Inc., Cerevance, Mitochon Pharmaceuticals, Inc., Peptilogics, Farmoquimica S/A, biOasis Technologies, Inc., HCA Healthcare, Inc. and Alzeca Biosciences, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Helminthic Infestations Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helminthic Infestations Therapeutics.

The Helminthic Infestations Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Helminthic Infestations Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Helminthic Infestations Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Benzimidazole

1.2.3 Pyrantel

1.2.4 Piperazine Citrate

1.2.5 Others

1.3 Market by Application

1.3.1 Global Helminthic Infestations Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Enterobius vermicularis

1.3.3 Taenia saginata

1.3.4 Ascaris lumbricoides

1.3.5 Trichuris trichiura

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Helminthic Infestations Therapeutics Market Perspective (2018-2029)

2.2 Helminthic Infestations Therapeutics Growth Trends by Region

2.2.1 Global Helminthic Infestations Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Helminthic Infestations Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Helminthic Infestations Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Helminthic Infestations Therapeutics Market Dynamics

2.3.1 Helminthic Infestations Therapeutics Industry Trends

2.3.2 Helminthic Infestations Therapeutics Market Drivers

2.3.3 Helminthic Infestations Therapeutics Market Challenges

2.3.4 Helminthic Infestations Therapeutics Market Restraints

3.1 Global Top Helminthic Infestations Therapeutics Players by Revenue

3.1.1 Global Top Helminthic Infestations Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Helminthic Infestations Therapeutics Revenue

3.4 Global Helminthic Infestations Therapeutics Market Concentration Ratio

3.4.1 Global Helminthic Infestations Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Helminthic Infestations Therapeutics Revenue in 2022

3.5 Helminthic Infestations Therapeutics Key Players Head office and Area Served

3.6 Key Players Helminthic Infestations Therapeutics Product Solution and Service

3.7 Date of Enter into Helminthic Infestations Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Helminthic Infestations Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Helminthic Infestations Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Helminthic Infestations Therapeutics Market Size (2018-2029)

6.2 North America Helminthic Infestations Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Helminthic Infestations Therapeutics Market Size by Country (2018-2023)

6.4 North America Helminthic Infestations Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Helminthic Infestations Therapeutics Market Size (2018-2029)

7.2 Europe Helminthic Infestations Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Helminthic Infestations Therapeutics Market Size by Country (2018-2023)

7.4 Europe Helminthic Infestations Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Helminthic Infestations Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Helminthic Infestations Therapeutics Market Size (2018-2029)

9.2 Latin America Helminthic Infestations Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Helminthic Infestations Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Helminthic Infestations Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Helminthic Infestations Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Neural Analytics, Inc.

11.1.1 Neural Analytics, Inc. Company Detail

11.1.2 Neural Analytics, Inc. Business Overview

11.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Introduction

11.1.4 Neural Analytics, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.1.5 Neural Analytics, Inc. Recent Development

11.2 M3 Biotechnology, Inc.

11.2.1 M3 Biotechnology, Inc. Company Detail

11.2.2 M3 Biotechnology, Inc. Business Overview

11.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Introduction

11.2.4 M3 Biotechnology, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.2.5 M3 Biotechnology, Inc. Recent Development

11.3 Cerevance

11.3.1 Cerevance Company Detail

11.3.2 Cerevance Business Overview

11.3.3 Cerevance Helminthic Infestations Therapeutics Introduction

11.3.4 Cerevance Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.3.5 Cerevance Recent Development

11.4 Mitochon Pharmaceuticals, Inc.

11.4.1 Mitochon Pharmaceuticals, Inc. Company Detail

11.4.2 Mitochon Pharmaceuticals, Inc. Business Overview

11.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Introduction

11.4.4 Mitochon Pharmaceuticals, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.4.5 Mitochon Pharmaceuticals, Inc. Recent Development

11.5 Peptilogics

11.5.1 Peptilogics Company Detail

11.5.2 Peptilogics Business Overview

11.5.3 Peptilogics Helminthic Infestations Therapeutics Introduction

11.5.4 Peptilogics Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.5.5 Peptilogics Recent Development

11.6 Farmoquimica S/A

11.6.1 Farmoquimica S/A Company Detail

11.6.2 Farmoquimica S/A Business Overview

11.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Introduction

11.6.4 Farmoquimica S/A Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.6.5 Farmoquimica S/A Recent Development

11.7 biOasis Technologies, Inc.

11.7.1 biOasis Technologies, Inc. Company Detail

11.7.2 biOasis Technologies, Inc. Business Overview

11.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Introduction

11.7.4 biOasis Technologies, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.7.5 biOasis Technologies, Inc. Recent Development

11.8 HCA Healthcare, Inc.

11.8.1 HCA Healthcare, Inc. Company Detail

11.8.2 HCA Healthcare, Inc. Business Overview

11.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Introduction

11.8.4 HCA Healthcare, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.8.5 HCA Healthcare, Inc. Recent Development

11.9 Alzeca Biosciences, Inc.

11.9.1 Alzeca Biosciences, Inc. Company Detail

11.9.2 Alzeca Biosciences, Inc. Business Overview

11.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Introduction

11.9.4 Alzeca Biosciences, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.9.5 Alzeca Biosciences, Inc. Recent Development

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Detail

11.10.2 Johnson & Johnson Business Overview

11.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Introduction

11.10.4 Johnson & Johnson Revenue in Helminthic Infestations Therapeutics Business (2018-2023)

11.10.5 Johnson & Johnson Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Benzimidazole

    Table 3. Key Players of Pyrantel

    Table 4. Key Players of Piperazine Citrate

    Table 5. Key Players of Others

    Table 6. Global Helminthic Infestations Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Helminthic Infestations Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Helminthic Infestations Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Helminthic Infestations Therapeutics Market Share by Region (2018-2023)

    Table 10. Global Helminthic Infestations Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Helminthic Infestations Therapeutics Market Share by Region (2024-2029)

    Table 12. Helminthic Infestations Therapeutics Market Trends

    Table 13. Helminthic Infestations Therapeutics Market Drivers

    Table 14. Helminthic Infestations Therapeutics Market Challenges

    Table 15. Helminthic Infestations Therapeutics Market Restraints

    Table 16. Global Helminthic Infestations Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Helminthic Infestations Therapeutics Market Share by Players (2018-2023)

    Table 18. Global Top Helminthic Infestations Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helminthic Infestations Therapeutics as of 2022)

    Table 19. Ranking of Global Top Helminthic Infestations Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Helminthic Infestations Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Helminthic Infestations Therapeutics Product Solution and Service

    Table 23. Date of Enter into Helminthic Infestations Therapeutics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Helminthic Infestations Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2018-2023)

    Table 27. Global Helminthic Infestations Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2024-2029)

    Table 29. Global Helminthic Infestations Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2018-2023)

    Table 31. Global Helminthic Infestations Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2024-2029)

    Table 33. North America Helminthic Infestations Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Helminthic Infestations Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Helminthic Infestations Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Helminthic Infestations Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Helminthic Infestations Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Helminthic Infestations Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Helminthic Infestations Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Helminthic Infestations Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Helminthic Infestations Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Helminthic Infestations Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Helminthic Infestations Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Neural Analytics, Inc. Company Detail

    Table 49. Neural Analytics, Inc. Business Overview

    Table 50. Neural Analytics, Inc. Helminthic Infestations Therapeutics Product

    Table 51. Neural Analytics, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 52. Neural Analytics, Inc. Recent Development

    Table 53. M3 Biotechnology, Inc. Company Detail

    Table 54. M3 Biotechnology, Inc. Business Overview

    Table 55. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Product

    Table 56. M3 Biotechnology, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 57. M3 Biotechnology, Inc. Recent Development

    Table 58. Cerevance Company Detail

    Table 59. Cerevance Business Overview

    Table 60. Cerevance Helminthic Infestations Therapeutics Product

    Table 61. Cerevance Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 62. Cerevance Recent Development

    Table 63. Mitochon Pharmaceuticals, Inc. Company Detail

    Table 64. Mitochon Pharmaceuticals, Inc. Business Overview

    Table 65. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Product

    Table 66. Mitochon Pharmaceuticals, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 67. Mitochon Pharmaceuticals, Inc. Recent Development

    Table 68. Peptilogics Company Detail

    Table 69. Peptilogics Business Overview

    Table 70. Peptilogics Helminthic Infestations Therapeutics Product

    Table 71. Peptilogics Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 72. Peptilogics Recent Development

    Table 73. Farmoquimica S/A Company Detail

    Table 74. Farmoquimica S/A Business Overview

    Table 75. Farmoquimica S/A Helminthic Infestations Therapeutics Product

    Table 76. Farmoquimica S/A Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 77. Farmoquimica S/A Recent Development

    Table 78. biOasis Technologies, Inc. Company Detail

    Table 79. biOasis Technologies, Inc. Business Overview

    Table 80. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Product

    Table 81. biOasis Technologies, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 82. biOasis Technologies, Inc. Recent Development

    Table 83. HCA Healthcare, Inc. Company Detail

    Table 84. HCA Healthcare, Inc. Business Overview

    Table 85. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Product

    Table 86. HCA Healthcare, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 87. HCA Healthcare, Inc. Recent Development

    Table 88. Alzeca Biosciences, Inc. Company Detail

    Table 89. Alzeca Biosciences, Inc. Business Overview

    Table 90. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Product

    Table 91. Alzeca Biosciences, Inc. Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 92. Alzeca Biosciences, Inc. Recent Development

    Table 93. Johnson & Johnson Company Detail

    Table 94. Johnson & Johnson Business Overview

    Table 95. Johnson & Johnson Helminthic Infestations Therapeutics Product

    Table 96. Johnson & Johnson Revenue in Helminthic Infestations Therapeutics Business (2018-2023) & (US$ Million)

    Table 97. Johnson & Johnson Recent Development

    Table 98. Research Programs/Design for This Report

    Table 99. Key Data Information from Secondary Sources

    Table 100. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Helminthic Infestations Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Helminthic Infestations Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Benzimidazole Features

    Figure 4. Pyrantel Features

    Figure 5. Piperazine Citrate Features

    Figure 6. Others Features

    Figure 7. Global Helminthic Infestations Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Helminthic Infestations Therapeutics Market Share by Application: 2022 VS 2029

    Figure 9. Enterobius vermicularis Case Studies

    Figure 10. Taenia saginata Case Studies

    Figure 11. Ascaris lumbricoides Case Studies

    Figure 12. Trichuris trichiura Case Studies

    Figure 13. Others Case Studies

    Figure 14. Helminthic Infestations Therapeutics Report Years Considered

    Figure 15. Global Helminthic Infestations Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Helminthic Infestations Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Helminthic Infestations Therapeutics Market Share by Region: 2022 VS 2029

    Figure 18. Global Helminthic Infestations Therapeutics Market Share by Players in 2022

    Figure 19. Global Top Helminthic Infestations Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helminthic Infestations Therapeutics as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Helminthic Infestations Therapeutics Revenue in 2022

    Figure 21. North America Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Helminthic Infestations Therapeutics Market Share by Country (2018-2029)

    Figure 23. United States Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Helminthic Infestations Therapeutics Market Share by Country (2018-2029)

    Figure 27. Germany Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Helminthic Infestations Therapeutics Market Share by Region (2018-2029)

    Figure 35. China Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Helminthic Infestations Therapeutics Market Share by Country (2018-2029)

    Figure 43. Mexico Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Helminthic Infestations Therapeutics Market Share by Country (2018-2029)

    Figure 47. Turkey Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Helminthic Infestations Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Neural Analytics, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 50. M3 Biotechnology, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 51. Cerevance Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 52. Mitochon Pharmaceuticals, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 53. Peptilogics Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 54. Farmoquimica S/A Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 55. biOasis Technologies, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 56. HCA Healthcare, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 57. Alzeca Biosciences, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 58. Johnson & Johnson Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2018-2023)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed